A screening program for trisomy 21 at 10 – 14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A - Spencer, K; Souter, V; Tul, N (Ultrasound Obstet Gynecol, 1999)
et al.